Alnylam Pharmaceuticals: Building Value from the IP Estate (B) Case Solution
This is just an excerpt. This case is about TECHNOLOGY & OPERATIONS
PUBLICATION DATE: November 14, 2016
The innovator of a pioneering biotech business in the siRNA area weighs his choices for scaling manufacturing capability in advance of an expected business launch. Functional intricacy and relative benefits of internal production versus a specialist design are talked about.
Related Case Solutions & Analyses:
Zhejiang Corporation of China Telecom
Learning to Lead in China: Michael Faye Goes to China
Oracle Corp.
AIC Netbooks: Optimizing Product Assembly
Yahoo: Both Sides of the Stamped Deal
Embracing Digital Technology: A New Strategic Imperative
(Re)Building a Global Team: Tariq Khan at Tek
Cisco Systems and its Community Fellowship Program
Who Moved My Shared Service Centre?
VidaGas: VillageReach – The Mozambican Foundation for Community Development Joint Venture
